NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants
In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available
Joseph Cullen, Cancer Prevention Leader, Dead At 54
‘Major Discover’ At FCRDC Is NF1 Gene, Report Says
DCT Advisors Reject MRS Concept, Approve RDOG Expansion
DCT Board Approves Drug Development Recompetition
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- George Sigounas named the first-ever chief science advisor at NCI
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State